36
Participants
Start Date
May 30, 2018
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Biopsy Procedure
Undergo a tumor biopsy
Biospecimen Collection
Undergo collection of blood
Computed Tomography
Undergo a CT scan
Edodekin alfa
Given SC
Magnetic Resonance Imaging
Undergo a MRI
Pembrolizumab
Given IV
Positron Emission Tomography
Undergo a PET scan
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
VCU Massey Comprehensive Cancer Center, Richmond
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Duke University Medical Center, Durham
Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta
University of Florida Health Science Center - Gainesville, Gainesville
Cleveland Clinic Foundation, Cleveland
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at Christian Hospital, St Louis
Siteman Cancer Center at West County Hospital, Creve Coeur
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
University of Texas Health Science Center at San Antonio, San Antonio
UCHealth University of Colorado Hospital, Aurora
UCSF Medical Center-Mount Zion, San Francisco
University of California Davis Comprehensive Cancer Center, Sacramento
Smilow Cancer Center/Yale-New Haven Hospital, New Haven
Yale University, New Haven
Massachusetts General Hospital Cancer Center, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Rutgers Cancer Institute of New Jersey, New Brunswick
National Cancer Institute (NCI)
NIH